Discovery Labs' Aerosolized KL4 Surfactant Significantly Improves Lung Function and Survival in Established Model of Acute Lung Injury (DSCO)

Discovery Laboratories DSCO, announced that new data from a study using aerosolized KL4 surfactant demonstrated a significant improvement in lung function and survival when treating Acute Lung Injury in a well-established preclinical model of this severe respiratory condition. The study was presented at the Pediatric Academic Societies Annual Meeting, internationally recognized as the largest, most relevant medical meeting dedicated to pediatric research.